BioCentury
ARTICLE | Clinical News

Single-agent ribavirin regulatory update

April 7, 2014 7:00 AM UTC

Pharmascience's Pendopharm division said Health Canada granted Priority Review to an application for single-agent ribavirin to treat HCV infection. Pendopharm said that ribavirin is available only in ...